Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Scott Randall Plotkin, MD, PhD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00657202
First received: March 27, 2008
Last updated: July 6, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)